NEUROONE MEDICAL TECHNOLOGIES Corp
For the period ended Dec 31, 2025. Filed Feb 17, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Dec 31, 2025 · Filed Feb 17, 2026
NMTC$0.89+0.7%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 1. Financial Statements
Condensed Balance Sheets
| As of | ||
|---|---|---|
| December 31, | September 30, | |
| 2025 | 2025 | |
| (Unaudited) | ||
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $3,561,616 | $6,570,382 |
| Accounts receivable | 2,661,867 | 1,264,805 |
| Inventory, net | 1,666,147 | 2,226,805 |
| Deferred offering costs | 22,920 | 22,920 |
| Prepaid expenses | 154,527 | 141,372 |
| Total current assets | 8,067,077 | 10,226,284 |
| Intangible assets, net | 39,368 | 44,946 |
| Right-of-use asset | 226,251 | 255,195 |
| Property and equipment, net | 244,906 | 259,222 |
| Total assets | $8,577,602 | $10,785,647 |
| Liabilities and Stockholders’ Equity | ||
| Current liabilities: | ||
| Accounts payable | $552,332 | $1,010,369 |
| Accrued expenses and other liabilities | 706,112 | 1,292,714 |
| Total current liabilities | 1,258,444 | 2,303,083 |
| Warrant liability | 806,859 | 1,266,894 |
| Operating lease liability, long term | 110,374 | 143,148 |
| Total liabilities | 2,175,677 | 3,713,125 |
| Commitments and contingencies (Note 4) | ||
| Stockholders’ equity: | ||
| Preferred stock, $0.001 par value; 10,000,000 shares authorized; no shares issued or outstanding. | — | — |
| Common stock, $0.001 par value; 100,000,000 shares authorized; 50,413,148 and 50,006,464 shares issued and outstanding as of December 31, 2025 and September 30, 2025, respectively. | 50,413 | 50,006 |
| Additional paid–in capital | 86,399,189 | 85,632,303 |
| Accumulated deficit | (80,047,677) | (78,609,787) |
| Total stockholders’ equity | 6,401,925 | 7,072,522 |
| Total liabilities and stockholders’ equity | $8,577,602 | $10,785,647 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.